Russian expert says North Korea takes first step to finding compromise with USWorld August 16, 18:27
1,000 Baltic Sea Fleet marines take part in wargame in Russia's northwestMilitary & Defense August 16, 18:10
Solovetsky Islands: Russia's UNESCO treasure in the White SeaSociety & Culture August 16, 18:02
German foreign minister warns New START and INF Treaties termination will affect EuropeWorld August 16, 17:37
Russian female weightlifter Vorobyova slapped with 8-year ban over doping abuseSport August 16, 17:36
George R. R. Martin believes killing off book characters makes readers truly careSociety & Culture August 16, 16:55
Western chemical weapons in Syria indicate true attitude to international law — diplomatRussian Politics & Diplomacy August 16, 16:54
Syrian diplomat stresses Khan Shaykhun incident staged by militantsWorld August 16, 15:46
EU, Russia and Turkey among Ukraine’s biggest trade export partnersBusiness & Economy August 16, 15:42
MOSCOW, March 17. /TASS/. The World Anti-Doping Agency (WADA) still has not answered to the Latvian pharmaceutical firm Grindex why the company’s produced mildronate was included in the list of the banned substances, Grindex spokeswoman Laila Klavina told TASS on Thursday.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016.
"It was last summer, when Grindex jointly with the Anti-Doping Department of the Latvian State Center for Athletics Medicine provided WADA with all arguments, proof and reasoning why the drug should not be included in the list of the banned substances," Klavina said in an interview with TASS.
"There was still no information from WADA last autumn, when it became obvious that meldonium would be on the list," she added. "All we know as of now is that meldonium on the list of the banned substances. Meanwhile, there is still no response from WADA."
Last week Grindex announced on its website that "Mildronate is widely used in the clinical practice."
"During increased physical activity, it restores the oxygen balance of tissue cells as well as it activates the metabolic processes that results in lower requirements of oxygen consumption for energy production," according to Grindex. "Mildronate is widely recognized by health care professionals and patients, and this may include athletes as well."
Russian sports was hit last week by a new case in a chain of doping-related scandals after some of the country’s athletes tested positive for banned substance meldonium.
After the drug meldonium (mildronate) was included in WADA’s list of banned substances a number of Russian athletes tested positive for the banned substance.
Those who have proved to have used meldonium since are cyclist Eduard Vorganov, figure skater Yekaterina Bobrova, tennis player Maria Sharapova, skater Pavel Kulizhnikov, short-track skaters Semion Elistratov and Ekaterina Konstantinova, volleyball player Aleksandr Markin and biathlete Eduard Latypov.
The number of athletes from Russia as well as worldwide testing positive for banned meldonium keeps rising.
The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).